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Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) which was first identified in December 
2019 has been announced as a pandemic by the World 
Health Organization (WHO) in March 2020 after 
infecting millions of people all over the world [1]. 
According to the centers for disease control and 
prevention (CDC), some people are at higher risk for 
severe illness from COVID-19 including people over 65 
years old, people who live in nursing home or long 
term care facility, people with chronic lung disease, 
people who have serious heart conditions, people with 
severe obesity, diabetes, chronic kidney disease 
undergoing dialysis, liver disease, sickle cell anemia 
and immunocompromised like HIV positive 
individuals [2]. 
Previously it was believed that low count of CD4 
might protect HIV infected individuals from progress 
to the cytokine storm observed in COVID-19 patients 
[3], but later studies suggested low count of CD4 
(lower than 200 cells per microliter) may be associated 
with disease severity [4, 5]. According to a prospective 
cohort which investigates COVID-19 in HIV-infected 
individuals, it was demonstrated that HIV-infected 
individuals should be considered to have equal (HIV 
positive patients who are on regular antiretroviral 
treatment with normal CD4 count and low viral load) 
or even more risk of severe disease (especially 
                                                          
 *Corresponding author:  
Dr. Razieh Dowran, Ph.D
Department of Virology, School of Public Health,  
Tehran University of Medical Sciences, Tehran, Iran 




Received: August, 7, 2020 
Accepted: August, 15, 2020 
individuals with comorbidities, lower CD4 cell counts, 
or high HIV viral load) [5]. The genome of SARS-CoV-
2 was detected after approximately 40 days from the 
onset of symptoms in six (32%) individuals, it was 
remarkable that four of them had the severe disease or 
AIDS [5]. Moreover, they suggest that the SARS-CoV-
2 presentation in HIV positive patients may have 
similar or even worse outcomes to general population. 
It was also mentioned that these patients should be 
treated same as HIV negative individuals [5].     
Although there are numerous mysterious about 
SARS-CoV-2 and its effects on HIV positive 
individuals, the prevalence of COVID-19 in HIV 
positive patients and severity of the symptoms and 
illness in these people depend on different factors such 
as age, gender, CD4 count, viral load, body mass index 
(BMI), comorbidity, current antiretroviral therapy, 
smoking and even socioeconomic factors [3-6]. 
According to existing studies, symptoms of disease in 
HIV positive patients may be similar to HIV negative 
ones and the severity of symptoms in HIV positive 
individuals with COVID-19 were almost similar to HIV 
negative COVID-19 patients [4-7]. However, it should 
be noted that because of the small sample size of 
available studies the results may subject to bias and 
other studies in future may get it more sense.   
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